125 related articles for article (PubMed ID: 31748840)
1. Correction to: 4-Repeat tau seeds and templating subtypes as brain and CSF biomarkers of frontotemporal lobar degeneration.
Saijo E; Metrick MA; Koga S; Parchi P; Litvan I; Spina S; Boxer A; Rojas JC; Galasko D; Kraus A; Rossi M; Newell K; Zanusso G; Grinberg LT; Seeley WW; Ghetti B; Dickson DW; Caughey B
Acta Neuropathol; 2020 Jan; 139(1):79-81. PubMed ID: 31748840
[TBL] [Abstract][Full Text] [Related]
2. 4-Repeat tau seeds and templating subtypes as brain and CSF biomarkers of frontotemporal lobar degeneration.
Saijo E; Metrick MA; Koga S; Parchi P; Litvan I; Spina S; Boxer A; Rojas JC; Galasko D; Kraus A; Rossi M; Newell K; Zanusso G; Grinberg LT; Seeley WW; Ghetti B; Dickson DW; Caughey B
Acta Neuropathol; 2020 Jan; 139(1):63-77. PubMed ID: 31616982
[TBL] [Abstract][Full Text] [Related]
3. Tau Rather than TDP-43 Proteins are Potential Cerebrospinal Fluid Biomarkers for Frontotemporal Lobar Degeneration Subtypes: A Pilot Study.
Kuiperij HB; Versleijen AA; Beenes M; Verwey NA; Benussi L; Paterlini A; Binetti G; Teunissen CE; Raaphorst J; Schelhaas HJ; Küsters B; Pijnenburg YA; Ghidoni R; Verbeek MM
J Alzheimers Dis; 2017; 55(2):585-595. PubMed ID: 27662293
[TBL] [Abstract][Full Text] [Related]
4. ATN status in amnestic and non-amnestic Alzheimer's disease and frontotemporal lobar degeneration.
Cousins KAQ; Irwin DJ; Wolk DA; Lee EB; Shaw LMJ; Trojanowski JQ; Da Re F; Gibbons GS; Grossman M; Phillips JS
Brain; 2020 Jul; 143(7):2295-2311. PubMed ID: 32666090
[TBL] [Abstract][Full Text] [Related]
5. Multimarker synaptic protein cerebrospinal fluid panels reflect TDP-43 pathology and cognitive performance in a pathological cohort of frontotemporal lobar degeneration.
Cervantes González A; Irwin DJ; Alcolea D; McMillan CT; Chen-Plotkin A; Wolk D; Sirisi S; Dols-Icardo O; Querol-Vilaseca M; Illán-Gala I; Santos-Santos MA; Fortea J; Lee EB; Trojanowski JQ; Grossman M; Lleó A; Belbin O
Mol Neurodegener; 2022 Apr; 17(1):29. PubMed ID: 35395770
[TBL] [Abstract][Full Text] [Related]
6. Relationship between CSF tau biomarkers and structural brain MRI measures in frontotemporal lobar degeneration.
Fenu G; Oppo V; Serra G; Lorefice L; Di Sfefano F; Deagostini D; Mancosu C; Fadda E; Melis C; Siotto P; Cocco E; Melis M; Cossu G
J Neurol Sci; 2022 Nov; 442():120415. PubMed ID: 36115219
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein L1 is increased in frontotemporal lobar degeneration post-mortem brain but not in ante-mortem cerebrospinal fluid.
Hok-A-Hin YS; Dijkstra AA; Rábano A; Hoozemans JJ; Castillo L; Seelaar H; van Swieten JC; Pijnenburg YAL; Teunissen CE; Del Campo M
Neurobiol Dis; 2022 Oct; 172():105813. PubMed ID: 35820647
[TBL] [Abstract][Full Text] [Related]
8. Cerebrospinal Fluid Biomarkers in Autopsy-Confirmed Alzheimer Disease and Frontotemporal Lobar Degeneration.
Mattsson-Carlgren N; Grinberg LT; Boxer A; Ossenkoppele R; Jonsson M; Seeley W; Ehrenberg A; Spina S; Janelidze S; Rojas-Martinex J; Rosen H; La Joie R; Lesman-Segev O; Iaccarino L; Kollmorgen G; Ljubenkov P; Eichenlaub U; Gorno-Tempini ML; Miller B; Hansson O; Rabinovici GD
Neurology; 2022 Mar; 98(11):e1137-e1150. PubMed ID: 35173015
[TBL] [Abstract][Full Text] [Related]
9. A 2-Step Cerebrospinal Algorithm for the Selection of Frontotemporal Lobar Degeneration Subtypes.
Lleó A; Irwin DJ; Illán-Gala I; McMillan CT; Wolk DA; Lee EB; Van Deerlin VM; Shaw LM; Trojanowski JQ; Grossman M
JAMA Neurol; 2018 Jun; 75(6):738-745. PubMed ID: 29554190
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic value of cerebrospinal fluid tau, neurofilament, and progranulin in definite frontotemporal lobar degeneration.
Goossens J; Bjerke M; Van Mossevelde S; Van den Bossche T; Goeman J; De Vil B; Sieben A; Martin JJ; Cras P; De Deyn PP; Van Broeckhoven C; van der Zee J; Engelborghs S
Alzheimers Res Ther; 2018 Mar; 10(1):31. PubMed ID: 29559004
[TBL] [Abstract][Full Text] [Related]
11. Cerebrospinal fluid biomarkers for Alzheimer's disease in patients with frontotemporal lobar degeneration and amyotrophic lateral sclerosis with the C9ORF72 repeat expansion.
Kämäläinen A; Herukka SK; Hartikainen P; Helisalmi S; Moilanen V; Knuuttila A; Jansson L; Tienari PJ; Remes AM
Dement Geriatr Cogn Disord; 2015; 39(5-6):287-93. PubMed ID: 25791939
[TBL] [Abstract][Full Text] [Related]
12. Correction to: Point estimate and reference normality interval of MRI-derived myocardial extracellular volume in healthy subjects: a systematic review and meta-analysis.
Sardanelli F; Schiaffino S; Zanardo M; Secchi F; Cannaò PM; Ambrogi F; Di Leo G
Eur Radiol; 2019 Dec; 29(12):7076-7077. PubMed ID: 31278579
[TBL] [Abstract][Full Text] [Related]
13. Correction to: Epicardial fat volume measured on nongated chest CT is a predictor of coronary artery disease.
Nagayama Y; Nakamura N; Itatani R; Oda S; Kusunoki S; Takahashi H; Nakaura T; Utsunomiya D; Yamashita Y
Eur Radiol; 2019 Dec; 29(12):7078-7079. PubMed ID: 31278578
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal Fluid YKL-40 and Chitotriosidase Levels in Frontotemporal Dementia Vary by Clinical, Genetic and Pathological Subtype.
Woollacott IOC; Nicholas JM; Heller C; Foiani MS; Moore KM; Russell LL; Paterson RW; Keshavan A; Schott JM; Warren JD; Heslegrave A; Zetterberg H; Rohrer JD
Dement Geriatr Cogn Disord; 2020; 49(1):56-76. PubMed ID: 32344399
[TBL] [Abstract][Full Text] [Related]
15. Correction to: Fewer patients undergo surgery when adding a comprehensive geriatric assessment in older patients with a hip fracture.
van der Zwaard BC; Stein CE; Bootsma JEM; van Geffen HJAA; Douw CM; Keijsers CJPW
Arch Orthop Trauma Surg; 2020 Apr; 140(4):493. PubMed ID: 31784836
[TBL] [Abstract][Full Text] [Related]
16. Cerebrospinal Fluid Biomarkers for the Differential Diagnosis between Alzheimer's Disease and Frontotemporal Lobar Degeneration: Systematic Review, HSROC Analysis, and Confounding Factors.
Rivero-Santana A; Ferreira D; Perestelo-Pérez L; Westman E; Wahlund LO; Sarría A; Serrano-Aguilar P
J Alzheimers Dis; 2017; 55(2):625-644. PubMed ID: 27716663
[TBL] [Abstract][Full Text] [Related]
17. Cerebrospinal fluid Aβ40 is similarly reduced in patients with Frontotemporal Lobar Degeneration and Alzheimer's Disease.
Baldeiras I; Santana I; Leitão MJ; Ribeiro MH; Pascoal R; Duro D; Lemos R; Santiago B; Almeida MR; Oliveira CR
J Neurol Sci; 2015 Nov; 358(1-2):308-16. PubMed ID: 26388316
[TBL] [Abstract][Full Text] [Related]
18. YKL-40 changes are not detected in post-mortem brain of patients with Alzheimer's disease and frontotemporal lobar degeneration.
Hok-A-Hin YS; Hoozemans JJM; Hu WT; Wouters D; Howell JC; Rábano A; van der Flier WM; Pijnenburg YAL; Teunissen CE; Del Campo M
Alzheimers Res Ther; 2022 Jul; 14(1):100. PubMed ID: 35879733
[TBL] [Abstract][Full Text] [Related]
19. Severity of gliosis in Pick's disease and frontotemporal lobar degeneration: tau-positive glia differentiate these disorders.
Schofield E; Kersaitis C; Shepherd CE; Kril JJ; Halliday GM
Brain; 2003 Apr; 126(Pt 4):827-40. PubMed ID: 12615642
[TBL] [Abstract][Full Text] [Related]
20. Making the diagnosis of frontotemporal lobar degeneration.
Bigio EH
Arch Pathol Lab Med; 2013 Mar; 137(3):314-25. PubMed ID: 23451743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
